Regeneus Revenue and Competitors

Pymble,

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Regeneus's estimated annual revenue is currently $2M per year.(i)
  • Regeneus's estimated revenue per employee is $155,000

Employee Data

  • Regeneus has 13 Employees.(i)
  • Regeneus grew their employee count by -24% last year.

Regeneus's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M27-7%N/AN/A
#10
$10.1M655%N/AN/A
Add Company

What Is Regeneus?

Regeneus Ltd (ASX: RGS) is a clinical-stage biotech company developing innovative first-in-class stem cell, exosome and immuno-oncology therapies that address significant unmet medical needs.

keywords:N/A

N/A

Total Funding

13

Number of Employees

$2M

Revenue (est)

-24%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Regeneus News

2022-04-20 - Global Rheumatoid Arthritis Stem Cell Therapy Market 2022 ...

Mesoblast; Roslin Cells; Regeneus; ReNeuron Group; International Stem Cell Corporation; Takeda. The report explores the regional and country...

2022-04-17 - Canine Stem Cell Therapy Market Analysis, Research Study ...

VETSTEM BIOPHARMA, Cell Therapy Sciences, Regeneus, Aratana Therapeutics, Medivet Biologics, Okyanos. Report overview:.

2022-04-17 - Veterinary Vaccine Market Is Booming Worldwide 2022-2028 ...

Veterinary Vaccine Market Is Booming Worldwide 2022-2028 | Aratana Therapeutics, Inc., Regeneus Ltd., Morphogenesis, Inc.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5.1M44N/AN/A
#2
N/A7722%N/A
#3
$28.1M104-2%N/A
#4
$15.5M107-4%N/A
#5
$18.3M112-9%N/A